Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholecystitis01:20

Cholecystitis

29
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
29

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of liver resections for neuroendocrine tumor liver metastases in carcinoid heart disease.

Journal of neuroendocrinology·2026
Same author

Do surgeons dream of electric sheep? The cost of favoring artificial intelligence over human judgment in surgery and surgical science.

Surgery·2026
Same author

Current Considerations in Nonoperative Surveillance of Intraductal Papillary Mucinous Neoplasms.

Digestive disease interventions·2026
Same author

Health-Related Quality of Life Post Gastrectomy: A Quantitative and Qualitative Cross-Sectional Analysis.

The Journal of surgical research·2026
Same author

Mortality after pancreatoduodenectomy for pancreatic malignancy: improving patient selection and safety of the operative technique.

Surgical oncology·2026
Same author

ASO Visual Abstract: The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases-A Retrospective Single-Center Analysis.

Annals of surgical oncology·2026

Related Experiment Video

Updated: May 2, 2026

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

4.9K

Hilar cholangiocarcinoma.

Victor M Zaydfudim1, Charles B Rosen2, David M Nagorney3

  • 1Department of Surgery, University of Virginia, 1300 Jefferson Park Avenue, Charlottesville, VA 22908, USA.

Surgical Oncology Clinics of North America
|February 25, 2014
PubMed
Summary

Optimal hilar cholangiocarcinoma treatment requires multidisciplinary evaluation. Resection or transplantation success depends on cancer stage, liver remnant, and absence of metastases, with specific surgical approaches for venous involvement.

Keywords:
Hepatic resectionHilar cholangiocarcinomaLiver transplantationVascular resection

More Related Videos

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

254
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

995

Related Experiment Videos

Last Updated: May 2, 2026

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
09:19

Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma

Published on: July 14, 2022

4.9K
Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

254
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

995

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Gastroenterology

Background:

  • Hilar cholangiocarcinoma (CCA) presents complex treatment challenges.
  • Optimal management strategies are crucial for improving patient outcomes.

Purpose of the Study:

  • To outline the optimal treatment pathways for hilar cholangiocarcinoma.
  • To define criteria for surgical resection and liver transplantation eligibility.

Main Methods:

  • Review of current treatment guidelines and clinical evidence for hilar cholangiocarcinoma.
  • Emphasis on multidisciplinary team (MDT) approach and high-volume center management.
  • Criteria for resectability and transplantation including staging and functional liver remnant assessment.

Main Results:

  • Treatment success hinges on cancer location, biliary/vascular involvement, and absence of distant metastases.
  • Adequate functional liver remnant and negative ductal margins are essential for resection.
  • Ipsilateral portal vein resection and reconstruction are indicated for venous involvement.
  • Neoadjuvant chemoradiation followed by liver transplantation offers the best option for unresectable cases without nodal/distant metastases or for patients with chronic liver disease.

Conclusions:

  • Multidisciplinary management at specialized centers is paramount for optimizing hilar cholangiocarcinoma treatment.
  • Careful patient selection based on disease extent and liver function is critical for successful surgical outcomes.
  • Liver transplantation with neoadjuvant therapy is a key strategy for select unresectable hilar cholangiocarcinoma patients.